Page last updated: 2024-08-21

psilocybin and s,n,n'-tripropylthiocarbamate

psilocybin has been researched along with s,n,n'-tripropylthiocarbamate in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ross, S1
Carhart-Harris, RL; Gabay, AS; Kempton, MJ; Mazibuko, N; Mehta, MA; Morrison, PD; Nutt, DJ1

Trials

1 trial(s) available for psilocybin and s,n,n'-tripropylthiocarbamate

ArticleYear
Psilocybin and MDMA reduce costly punishment in the Ultimatum Game.
    Scientific reports, 2018, 05-29, Volume: 8, Issue:1

    Topics: Adult; Altruism; Community-Based Participatory Research; Decision Making; Emotions; Games, Experimental; Healthy Volunteers; Humans; Interpersonal Relations; Male; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Psychopharmacology; Punishment; Rejection, Psychology; Reward; Social Behavior; Socialization; Young Adult

2018

Other Studies

1 other study(ies) available for psilocybin and s,n,n'-tripropylthiocarbamate

ArticleYear
Serotonergic hallucinogens and emerging targets for addiction pharmacotherapies.
    The Psychiatric clinics of North America, 2012, Volume: 35, Issue:2

    Topics: Adult; Animals; Behavior, Addictive; Clinical Trials as Topic; Cognition; Dopamine; Dopamine Agonists; Glutamates; Hallucinogens; Humans; Ibogaine; Lysergic Acid; Neuronal Plasticity; Nucleus Accumbens; Phytotherapy; Prefrontal Cortex; Psilocybin; Religion; Reward; Serotonin 5-HT2 Receptor Agonists; Substance Withdrawal Syndrome; Substance-Related Disorders

2012